Jason Shimiaie is an Emory graduate (class of 2010) with a B.S. in Neuroscience and behavioral biology. Although he scored a 36 (97th percentile) on his MCAT's, Jason no longer wishes to enter the world of medicine and now desired to become a member of wall street.
Ed Silverman is the founding editor of Pharmalot and a prize-winning journalist who has covered the pharmaceutical industry for the past 15 years for The Star-Ledger of New Jersey, The Pink Sheet and, currently, as an editor-at-large for Med Ad News and R&D Directions.
James Picerno is a financial journalist who has been writing about finance and investment theory for more than twenty years. He writes for trade magazines read by financial professionals and financial advisers. Over the years, he’s written for the Wall Street Journal, Barron’s, Bloomberg Markets, Mutual Funds, Modern Maturity, Investment Advisor, Reuters, and his popular finance blog, The CapitalSpectator.
Visit: The Capital Spectator (www.capitalspectator.com)
NYC Trader currently works in a public policy role as a Financial & Economic Analyst. He has obtained permission from his organization to publish pseudonymously.
NYC Trader started out his career as an underwriter at a commodities brokerage firm. He then joined several large financial institutions in various product areas, which included quantitative roles in the equities & derivatives space. Most recently, prior to joining his current organization, NYC Trader co-founded a boutique asset management firm where he was a portfolio manager responsible for the firm's diversified portfolio of assets.
NYC Trader holds his MBA in Finance and Strategy from a top university.
Additional disclaimer by NYC Trader:
The views in my articles represent my views only and not the views of any company that I am affiliated with. The articles I write are intended for informational and educational purposes only and shall not be construed to constitute investment advice. Nothing contained in my articles shall constitute a solicitation, recommendation, or endorsement to buy or sell any security or private fund.